FOLH1 and neoplasm: Furthermore, BAY1075553 [2-PMPA analogs (2S, 4S)-2-18F-fluoro-4-(phosphonomethyl) pentanedioid acid] has demonstrated high uptake in PSMA+ LNCaP tumor xenografts (44).